Most children with cancer in rich countries are cured; most in poor countries are not, often because cheap drugs are missing. A global platform now ships quality drugs free; scaling it to 50 countries would be one of the highest-value cancer interventions available.
The WHO and St. Jude Global Platform for Access to Childhood Cancer Medicines began deliveries in 2025 to a first set of countries, providing an uninterrupted supply of quality-assured medicines at no cost. Childhood cancers are highly curable with generic drugs, so the return per dollar is very high. The proposal is to commit the funding and logistics to reach 50 countries and to measure survival, not deliveries, as the outcome.
Shares Paediatric oncology roadmap: cooperative-group cures → engineered immunity → drugs developed for children first, Neuroblastoma (paediatric), Rare and paediatric cancers without markets, Most of the world has almost no cancer care.
Shares Paediatric oncology roadmap: cooperative-group cures → engineered immunity → drugs developed for children first, Neuroblastoma (paediatric), Rare and paediatric cancers without markets, Acute lymphoblastic leukaemia.
Shares Paediatric oncology roadmap: cooperative-group cures → engineered immunity → drugs developed for children first, Most of the world has almost no cancer care, Hodgkin lymphoma, Acute lymphoblastic leukaemia.
Shares Paediatric oncology roadmap: cooperative-group cures → engineered immunity → drugs developed for children first, Neuroblastoma (paediatric), Rare and paediatric cancers without markets, Acute lymphoblastic leukaemia.
Shares Paediatric oncology roadmap: cooperative-group cures → engineered immunity → drugs developed for children first, Neuroblastoma (paediatric), Rare and paediatric cancers without markets, Acute lymphoblastic leukaemia.
Shares Paediatric oncology roadmap: cooperative-group cures → engineered immunity → drugs developed for children first, Rare and paediatric cancers without markets.
Shares Paediatric oncology roadmap: cooperative-group cures → engineered immunity → drugs developed for children first, Neuroblastoma (paediatric), Rare and paediatric cancers without markets.
Shares Paediatric oncology roadmap: cooperative-group cures → engineered immunity → drugs developed for children first, Neuroblastoma (paediatric), Rare and paediatric cancers without markets.